This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Feed Additive Development for Mycotoxins
BioVenic provides feed additive development services for mycotoxins to create safe and effective additives that mitigate mycotoxin risks in animal feed, supporting mycotoxin mitigation research and targeted additive product development. Our platform covers adsorbing agents (bentonites, aluminosilicates, activated carbons, yeast cell walls), biotransforming agents (bacteria, yeast, fungi, enzymes), and antioxidant additives, with mycotoxin analysis via ELISA, LFD, GC, and HPLC. We support additive validation with in vitro and in vivo models across pigs, poultry, ruminants, and companion animals, and multi-omics (microbiome, metabolome, proteome) analyses to evaluate safety and efficacy.
Animal Feed Mycotoxin Analysis
In conducting animal feed mycotoxin analysis, a range of methodologies are employed to address the distinct characteristics of each mycotoxin type. Our solutions for animal feed mycotoxin analysis provide precise and streamlined testing services catering to a wide array of mycotoxin varieties. These solutions encompass mycotoxin analytical techniques like ELISA, LFDs, GC, HPLC, and others.
Mycotoxin-Adsorbing Efficacy Evaluation
To evaluate the effectiveness of mycotoxin adsorption, diverse inorganic adsorbents-such as hydrated sodium calcium aluminosilicate, zeolites, bentonites, clays, and activated carbons-are tested and utilized as mycotoxin-adsorbing agents. Other options include components of yeast cell walls, synthetic polymers like cholestyramine and polyvinylpyrrolidone, humic substances, and dietary fibers. Our solutions aid in investigating their adsorbing efficacy under varied conditions.
Probiotics Additives Development for Mycotoxins
Certain probiotics have the capacity to reduce mycotoxins in animal feed via biotransformation, thus fostering animal growth and well-being. Our solutions for probiotics development in animal feed facilitate the study of the mitigating effects of bacteria, fungi, yeast, and other additives for mycotoxins.
Enzyme Additives Development For Mycotoxins
Some enzymes accelerate the conversion of mycotoxins into less harmful forms. Our solutions for enzyme feed additives encompass enzyme screening, optimization, recombinant production, and efficacy validation, aiding in the creation of potent feed enzymes to diminish mycotoxin risks to animals.
Animal Study for Development of Feed Additive for Mycotoxins
As various mycotoxins impact animal species differently, the effects of feed additives developed for these mycotoxins must be verified in animal models. We offer animal in vitro digestion and fermentation models, simulating the digestive and fermentative processes of animals to assess the additive's degradation effects on mycotoxins. Additionally, our in vivo animal models span across a range of species like pigs, poultry, ruminants, and companion animals, to explore the protective effects of feed additives on animals affected by mycotoxins. Analysis services for animal metabolites, biochemical indicators, microbial composition, and more are also provided. Through these animal study solutions, we aid in the development of effective and safe animal feed additives to mitigate the impacts of mycotoxins on animal health.
For more information about our animal study solutions, please visit the following links.
Feed Additive Development for Mycotoxins
In our pursuit of Feed Additive Product Development for Mycotoxins, we specialize in selecting feed additives, formulating them rationally, and verifying their application effects to create products that are both safe and effective. Our focus lies in the practical application efficacy of these products, crafting targeted feed additives tailored to specific animal species or mycotoxins.
For more information, please visit:
- Feed Aflatoxins Solution
- Feed Ochratoxins Solution
- Feed Fumonisins Solution
- Feed Trichothecenes Solution
- Feed Zearalenone Solution
- Feed Patulin Solution
Feed Additive Development Service Workflow
Common Feed Additives for Mycotoxins
Common feed additives for mycotoxins comprise adsorbing agents, biotransforming agents, and compounds that indirectly affect mycotoxins (e.g., antioxidant agents). The table below outlines the properties of some typical feed additives for mycotoxins along with examples:
Table. 1 Common feed additive for mycotoxins
| Type of Additives | Descriptions | Examples |
|---|---|---|
| Mycotoxin-adsorbing agents |
|
|
| Mycotoxin-biotransforming agents |
|
|
| Antioxidant agents |
|
|
Related Research
In a study investigating the protective effects of mycotoxin adsorbent galactomannan oligosaccharides (GMOS) on growth performance, fermentation parameters, mycotoxin residues, serum biochemistry, and hematology of goats fed mycotoxins-contaminated diets, both in vitro and in vivo experiments were conducted. The in vitro assay demonstrated that 0.05% GMOS outperformed yeast cell wall (YCW) and montmorillonite (MMT) in aflatoxin adsorption capacity, achieving >95% binding efficiency for aflatoxin B1 at pH 3.0 and >88% at pH 6.8. For the in vivo trial, 20 three-month-old Xiangdong black goats (15.0 ± 1.9 kg) were randomly divided into two dietary treatments: a multi-mycotoxins contaminated diet (control) and the contaminated diet supplemented with 0.05% GMOS, over a 42-day feeding period. Results demonstrated that GMOS supplementation significantly reduced aflatoxin M1 residues in milk by 42.3% and deoxynivalenol concentrations in serum by 37.8% compared to the control (p < 0.05). Serum biochemical analysis revealed that GMOS supplementation restored liver function markers, with alanine aminotransferase (ALT) and aspartate aminotransferase (AST) activities reduced to levels comparable to those in animals fed uncontaminated diets. Hematological parameters including red blood cell count, hemoglobin concentration, and white blood cell differential counts were maintained within normal physiological ranges in the GMOS group, indicating effective protection against mycotoxin-induced hematological disruption. Furthermore, rumen fermentation parameters including total volatile fatty acid (VFA) concentration and acetate-to-propionate ratio were preserved in GMOS-supplemented goats. This study establishes GMOS as a highly efficacious multi-mycotoxin adsorbent that protects ruminant health and productivity through selective toxin binding in the gastrointestinal tract, reducing systemic mycotoxin absorption and preserving hepatic, hematological, and ruminal function.
Fig. 1 The ability of GMOS to adsorb mycotoxins.1
Why Choose Us?
Tailored Development Process
We possess comprehensive expertise in developing various types of animal feed additives designed to target mycotoxins, allowing us to customize the development process to meet your specific research requirements.
Diverse Animal
Models
Our in vivo and in vitro animal models encompass a wide array of livestock, poultry, and companion animals, offering valuable benchmarks for the development of feed additives.
State-of-the-Art Technologies
We employ a range of advanced experimental technologies to comprehensively understand the application effects and mechanisms of action of feed additives from multiple perspectives.
Case Study
Researchers developed and validated a multi-mechanism mycotoxin mitigation additive employing a synergistic combination of adsorption and biotransformation strategies to achieve comprehensive toxin reduction in contaminated feed materials. The formulation integrated inorganic adsorbents (hydrated sodium calcium aluminosilicate and modified zeolite), organic binding agents (yeast cell wall components and activated carbon fibers), enzymatic biotransformation systems (epoxidase and lactonohydrolase preparations), and microbial detoxification agents (selected mycotoxin-transforming bacterial strains). The waterfall analysis demonstrated the stepwise contribution of each mechanism: initial mycotoxin contamination at 100% was first reduced by 35% through inorganic adsorption, followed by an additional 18% removal via organic binding mechanisms. Enzymatic biotransformation contributed a substantial 25% reduction by converting parent toxins into non-toxic metabolites, while microbial biotransformation provided a final 15% degradation through metabolic transformation processes.
Fig. 2 Case Study
Frequently Asked Questions
Q1: What types of mycotoxins can your feed additive development services target?
A: Our development services comprehensively cover major regulated and emerging mycotoxins commonly found in feedstuffs, including aflatoxins, zearalenone, ochratoxin A, deoxynivalenol (vomitoxin), and T-2 toxin.
Q2: What sample amount and preparation guidelines should we follow before sending feed additive candidates?
A: For preliminary laboratory evaluation and in vitro binding assays, we typically require at least 100 to 200 grams of homogenized raw additive powder, liquid extracts, or trial formulations packed in airtight, moisture-proof containers. Samples should be clearly labeled with batch identifiers and accompanied by a basic certificate of analysis or composition sheet if available. Because sample requirements can vary widely based on the specific analytical workflows or downstream animal trials needed, please reach out directly to our technical support staff to confirm exact shipping and preparation protocols.
Q3: What is the typical turnaround time for a complete feed additive development and validation project?
A: The overall timeline depends greatly on the project scope, ranging from initial in vitro screening and binding efficiency profiling to advanced stability and safety testing. Comprehensive development projects involving formulation optimization and trial support will require a customized timeline. For an accurate schedule tailored to your specific research and development goals, please get in touch with our technical support personnel.
With BioVenic's specialized animal feed additive development service focusing on mycotoxins, animal nutrition researchers can engage in mycotoxin analysis, explore the effects of various feed additives in vivo or in vitro, and create mycotoxin-specific feed additive products. If you are intrigued by our solutions, feel free to contact us. We are eager to learn more about your research program and provide effective solutions tailored to your needs.
Reference
- Wu, Yicheng, et al. "Effects of galactomannan oligosaccharides on growth performance, mycotoxin detoxification, serum biochemistry, and hematology of goats fed mycotoxins-contaminated diets." Frontiers in Veterinary Science 9 (2022): 852251. https://doi.org/10.3389/fvets.2022.852251. Distributed under Open Access license CC BY 4.0. Without modification.